SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-009385
Filing Date
2020-03-09
Accepted
2020-03-09 16:46:09
Documents
81
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K xene-10k_20191231.htm 10-K 2761981
2 EX-4.4 xene-ex44_540.htm EX-4.4 45966
3 EX-10.24 xene-ex1024_486.htm EX-10.24 155537
4 EX-10.25 xene-ex1025_485.htm EX-10.25 154550
5 EX-23.1 xene-ex231_7.htm EX-23.1 20013
6 EX-31.1 xene-ex311_9.htm EX-31.1 19969
7 EX-31.2 xene-ex312_6.htm EX-31.2 19789
8 EX-32.1 xene-ex321_10.htm EX-32.1 11558
9 EX-32.2 xene-ex322_8.htm EX-32.2 11520
10 GRAPHIC gqid5hl5j0yb000001.jpg GRAPHIC 2386
  Complete submission text file 0001564590-20-009385.txt   8888018

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT xene-20191231.xml EX-101.INS 1490762
12 XBRL TAXONOMY EXTENSION SCHEMA xene-20191231.xsd EX-101.SCH 67954
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xene-20191231_cal.xml EX-101.CAL 52932
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xene-20191231_def.xml EX-101.DEF 256233
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20191231_lab.xml EX-101.LAB 544842
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20191231_pre.xml EX-101.PRE 414818
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36687 | Film No.: 20698523
SIC: 2834 Pharmaceutical Preparations